PriceTargets.com logo

Alpha Teknova - TKNO Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $9.33
  • Forecasted Upside: 234.53%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$2.79 As of 09/29/2023 01:00 AM ET
▲ +0.09 (3.33%)

This chart shows the closing price for TKNO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Alpha Teknova Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TKNO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TKNO

Analyst Price Target is $9.33
▲ +234.53% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Alpha Teknova in the last 3 months. The average price target is $9.33, with a high forecast of $12.00 and a low forecast of $8.00. The average price target represents a 234.53% upside from the last price of $2.79.

This chart shows the closing price for TKNO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 1 investment analysts is to hold stock in Alpha Teknova. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/8/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/12/2023KeyCorpInitiated CoverageSector Weight ➝ Sector WeightLow
11/16/2022StephensLower Target$12.00Low
11/10/2022CowenLower Target$13.00 ➝ $8.00Low
11/10/2022CowenLower Target$13.00 ➝ $8.00Low
8/11/2022StephensLower TargetOverweight$22.00 ➝ $15.00Low
3/16/2022StephensLower TargetOverweight$30.00 ➝ $26.00High
10/14/2021CowenBoost TargetOutperform$24.00 ➝ $30.00High
7/20/2021William BlairReiterated RatingOutperformMedium
7/20/2021StephensInitiated CoverageOverweight$27.00High
7/20/2021BTIG ResearchInitiated CoverageBuy$26.00High
7/20/2021CowenInitiated CoverageOutperformHigh
(Data available from 9/30/2018 forward)

News Sentiment Rating

0.77 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Mentions as of
4/3/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2023
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2023
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2023
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2023
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2023

Current Sentiment

  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Alpha Teknova logo
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
Read More

Today's Range

Now: $2.79
Low: $2.63
High: $2.98

50 Day Range

MA: $2.47
Low: $1.66
High: $3.44

52 Week Range

Now: $2.79
Low: $1.62
High: $6.48

Volume

77,053 shs

Average Volume

245,619 shs

Market Capitalization

$79.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.08

Frequently Asked Questions

What sell-side analysts currently cover shares of Alpha Teknova?

The following equities research analysts have issued research reports on Alpha Teknova in the last year: Cowen Inc, Cowen Inc., KeyCorp, and Stephens.
View the latest analyst ratings for TKNO.

What is the current price target for Alpha Teknova?

3 Wall Street analysts have set twelve-month price targets for Alpha Teknova in the last year. Their average twelve-month price target is $9.33, suggesting a possible upside of 234.5%. Stephens has the highest price target set, predicting TKNO will reach $12.00 in the next twelve months. Cowen Inc. has the lowest price target set, forecasting a price of $8.00 for Alpha Teknova in the next year.
View the latest price targets for TKNO.

What is the current consensus analyst rating for Alpha Teknova?

Alpha Teknova currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TKNO, but not buy more shares or sell existing shares.
View the latest ratings for TKNO.

What other companies compete with Alpha Teknova?

Other companies that are similar to Alpha Teknova include Achieve Life Sciences, VolitionRx, Aspira Women's Health, ImmuCell and Trinity Biotech. Learn More about companies similar to Alpha Teknova.

How do I contact Alpha Teknova's investor relations team?

The company's listed phone number is 831-637-1100 and its investor relations email address is i[email protected]. The official website for Alpha Teknova is www.teknova.com. Learn More about contacing Alpha Teknova investor relations.